Mint Tower Capital Management’s Kindred Biosciences, Inc. KIN Stock Holding History

Mint Tower Capital Management’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-13,933	Closed	-$128K	–	400
2021 Q2	$128K	Buy	+13,933	New	+$81K	0.01%	302

Other funds holding KIN

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Mint Tower Capital Management's KIN Position: Q3 2021 in Review

Mint Tower Capital Management sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 13,933 shares — an estimated $128K sold.

Mint Tower Capital Management first reported a position in KIN in Q2 2021 and held it in 1 quarter. The position peaked at $128K in Q2 2021. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

Mint Tower Capital Management reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
Mint Tower Capital Management sold 13,933 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $128K.
Mint Tower Capital Management first reported a position in Kindred Biosciences, Inc. in Q2 2021 and held it in 1 quarter.
Mint Tower Capital Management's Kindred Biosciences, Inc. position peaked at $128K in Q2 2021.
1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on Mint Tower Capital Management's 13F filing for Q3 2021, filed 16 Nov 2021.